SOPH insider trades & Congress trades
SOPHiA GENETICS SA: public insider filings and Congress disclosures, in one place.
Bourse has recorded 40 open-market insider transactions in SOPHiA GENETICS SA (SOPH) (0 purchases with code P and 40 sales with code S), the most recent on October 13, 2026.
In the last 90 days: 0 purchases by 0 insiders ($0) and 32 sales by 10 ($1.69M).
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Oct 13, 2026 | Xu Zhenyu | Chief Scientific Officer | Sell | 4,000 | $7.18 | $29K | – |
| Oct 12, 2026 | Camblong Jurgi | Executive Chairman | Sell | 8,500 | $7.26 | $62K | – |
| Oct 12, 2026 | Menu Philippe | Chief Medical Officer | Sell | 5,000 | $7.26 | $36K | – |
| Oct 5, 2026 | Cardoza George | Chief Financial Officer | Sell | 1,592 | $8.10 | $13K | – |
| Oct 5, 2026 | Menu Philippe | Chief Medical Officer | Sell | 7,394 | $8.13 | $60K | – |
| Oct 5, 2026 | Camblong Jurgi | Executive Chairman | Sell | 40,172 | $8.13 | $327K | – |
| Oct 5, 2026 | Xu Zhenyu | Chief Scientific Officer | Sell | 7,394 | $8.12 | $60K | – |
| Oct 5, 2026 | Muken Ross | Chief Executive Officer | Sell | 9,838 | $8.13 | $80K | – |
| Oct 5, 2026 | Van Well Daan | Chief Legal Officer | Sell | 6,168 | $8.12 | $50K | – |
| Oct 5, 2026 | Valente Manuela | Chief People Officer | Sell | 4,240 | $8.13 | $34K | – |
| Oct 5, 2026 | Verma Abhimanyu | Chief Technology Officer | Sell | 5,284 | $8.12 | $43K | – |
| Oct 5, 2026 | Puylaert Kevin | Chief Sales Officer | Sell | 185 | $8.06 | $1K | – |
| Oct 5, 2026 | Puylaert Kevin | Chief Sales Officer | Sell | 31 | $7.92 | $246 | – |
| Sep 21, 2026 | Cardoza George | Chief Financial Officer | Sell | 774 | $8.33 | $6K | −0.1% |
| Sep 21, 2026 | Muken Ross | Chief Executive Officer | Sell | 422 | $8.33 | $4K | −0.1% |
| Sep 14, 2026 | Menu Philippe | Chief Medical Officer | Sell | 5,000 | $7.88 | $39K | −0.1% |
| Sep 14, 2026 | Xu Zhenyu | Chief Scientific Officer | Sell | 4,000 | $7.88 | $32K | −0.1% |
| Sep 11, 2026 | Van Well Daan | Chief Legal Officer | Sell | 6,168 | $7.63 | $47K | −0.1% |
| Sep 10, 2026 | Camblong Jurgi | Executive Chairman | Sell | 8,500 | $7.66 | $65K | −0.1% |
| Sep 8, 2026 | Hibbs Kathy L | Chief Administrative Officer | Sell | 6,250 | $8.13 | $51K | −0.0% |
| Aug 27, 2026 | Xu Zhenyu | Chief Scientific Officer | Sell | 10,000 | $8.91 | $89K | −0.0% |
| Aug 25, 2026 | Menu Philippe | Chief Medical Officer | Sell | 5,000 | $8.68 | $43K | −0.0% |
| Aug 25, 2026 | Hibbs Kathy L | Chief Administrative Officer | Sell | 6,250 | $8.68 | $54K | −0.0% |
| Aug 24, 2026 | Verma Abhimanyu | Chief Technology Officer | Sell | 5,000 | $8.80 | $44K | −0.0% |
| Aug 21, 2026 | Xu Zhenyu | Chief Scientific Officer | Sell | 5,408 | $8.40 | $45K | −0.1% |
| Aug 20, 2026 | Xu Zhenyu | Chief Scientific Officer | Sell | 4,592 | $8.41 | $39K | −0.1% |
| Aug 19, 2026 | Xu Zhenyu | Chief Scientific Officer | Sell | 10,000 | $7.94 | $79K | −0.1% |
| Aug 19, 2026 | Valente Manuela | Chief People Officer | Sell | 10,000 | $7.94 | $79K | −0.1% |
| Aug 19, 2026 | Verma Abhimanyu | Chief Technology Officer | Sell | 5,000 | $8.20 | $41K | −0.0% |
| Aug 13, 2026 | Xu Zhenyu | Chief Scientific Officer | Sell | 4,000 | $7.52 | $30K | +0.0% |
Showing the 30 most recent of 40 transactions.
Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.